Evaluation of Pancreatic Steatosis in Patients With Cancer of Pancreas

S

Soroka University Medical Center

Status

Unknown

Conditions

Cancer of Pancreas

Study type

Observational

Funder types

Other

Identifiers

NCT02682394
SOR0216-15CTIL

Details and patient eligibility

About

Prognostic Importance of Quantitative Magnetic Resonance Imaging for Evaluation of Pancreatic Steatosis in Patients with Pancreatic Cancer

Full description

Finding patients with pancreatic cancer (in all stages), before any treatment. Non invasively quantify fatty infiltration of pancreas using, MRI DIXON Scan in pancreatic cancer patient relatively to liver. Measuring cell-free blood DNA in those patients for evaluating the aggressiveness of the disease. Quantify the prognostic significance of pancreatic steatosis in comparison with clinical and pathological prognostic indexes used today.

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients diagnosed with any pancreatic cancer, in any stage, before treatment.
  • >18 y.o

Exclusion criteria

  • claustrophobia
  • GFR<30
  • patients with non mri compatible devices (e.g. orthopaedic external fixation system)
  • After chemotherapy treatment or surgical procedure

Trial contacts and locations

1

Loading...

Central trial contact

Irena Lazerev, MD; Vladimir Borodetsky, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems